AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.

Scientists synthesized inaoside A from mushrooms, unlocking its bioactive potential for functional foods and medicines.

A team of scientists has developed a groundbreaking approach using specially designed peptides to improve drug formulations.

Insilico Medcine( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced the first patient has been dosed in the global multicenter Phase I ...

Immunopathologies encompass a range of conditions known for their defined pathophysiology but lack safe and effective treatment options. These diseases ...

The AI drug discovery market is worth about $1.4 billion ... new white paper from Altmetric – ‘The changing landscape of journal performance measurement’ – learn how publication planners ...

Discover the potential of macrocycles in drug discovery: flexible, cell-permeable molecules targeting undruggable proteins.

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...

The successful and safe delivery of therapeutics relies on understanding how easily drugs can pass through biological barriers which protect cells.

The memo, sent by acting Homeland Security Secretary Benjamine Huffman, says DHS is granting immigration-enforcement authority to several agencies at the Justice Department, including the Drug ...

As we enter into 2025, it’s crucial not to let the ongoing drug poisoning crisis get lost amid an overwhelming number of critical issues facing our city and province. Despite a decline in drug ...

In 2019, the Republican conferences in the New York State Legislature argued stridently against the passage of Bail and Discovery reform on the floors of the New York State Assembly and Senate.